Literature DB >> 16263755

Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation.

Charlly Kao1, Mark A Daniels, Stephen C Jameson.   

Abstract

The capacity of T cells to bind peptide/MHC ligands changes with T cell development and differentiation. Here we study changes in peptide/MHC multimer binding following T cell activation. Surprisingly, T cell activation caused a marked reduction in specific peptide/MHC Class I multimer binding, which was distinct from transient TCR down-regulation, and was especially dramatic for engagement with low-affinity peptide/MHC ligands. Direct CD8-Class I interactions were also profoundly and rapidly impaired following T cell stimulation, even though surface CD8alpha and CD8beta levels were unchanged after activation, suggesting that decreased CD8 co-receptor binding contributes to this effect. Finally, we show that enzymatic desialylation restores much of the multimer binding on activated T cells, suggesting that altered glycosylation may inhibit TCR/CD8 binding to peptide/MHC ligands. These radical changes in activated T cells' ability to perceive peptide/MHC ligands may contribute to selective outgrowth of clones with high affinity for the stimulatory ligand.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263755     DOI: 10.1093/intimm/dxh340

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  19 in total

1.  Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Christopher D Dupont; Elia D Tait; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2010-11       Impact factor: 4.823

2.  Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research.

Authors:  Philippe Guillaume; Danijel Dojcinovic; Immanuel F Luescher
Journal:  Cancer Immun       Date:  2009-09-25

3.  Modulation of MHC binding by lateral association of TCR and coreceptor.

Authors:  Karlo Perica; Joan Glick Bieler; Michael Edidin; Jonathan Schneck
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

4.  Interferon γ limits the effectiveness of melanoma peptide vaccines.

Authors:  Hyun-Il Cho; Young-Ran Lee; Esteban Celis
Journal:  Blood       Date:  2010-10-01       Impact factor: 22.113

5.  Dose-dependent modulation of CD8 and functional avidity as a result of peptide encounter.

Authors:  Charles J Kroger; Martha A Alexander-Miller
Journal:  Immunology       Date:  2007-05-02       Impact factor: 7.397

Review 6.  Mammalian glycosylation in immunity.

Authors:  Jamey D Marth; Prabhjit K Grewal
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

7.  Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells.

Authors:  Rodolfo José Chaparro; Amanda R Burton; David V Serreze; Dario A A Vignali; Teresa P DiLorenzo
Journal:  J Immunol Methods       Date:  2008-04-08       Impact factor: 2.303

Review 8.  T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.

Authors:  Jennifer D Stone; Adam S Chervin; David M Kranz
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

9.  Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses.

Authors:  Leonardo Freire-de-Lima; Frederico Alisson-Silva; Sebastião T Carvalho; Christina M Takiya; Maurício M Rodrigues; George A DosReis; Lucia Mendonça-Previato; José O Previato; Adriane R Todeschini
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

10.  Self-class I MHC molecules support survival of naive CD8 T cells, but depress their functional sensitivity through regulation of CD8 expression levels.

Authors:  Kensuke Takada; Stephen C Jameson
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.